AERIE PHARMACEUTICALS INC of Bedminster, NJ, a company, filed a Form D amendment with the SEC on 2013-08-29. The offering totals $18.0M, of which $15.0M was reported sold. Industry: Biotechnology.
Showing 25 of 33 people.
| Name | Role | Location |
|---|---|---|
| JANET CONWAY | Director | BEDMINSTER, NJ |
| MURRAY J GOLDBERG | Director | BEDMINSTER, NJ |
| David Mack | Director | Cranbury, NJ |
| THOMAS J MITRO | Executive Officer | BEDMINSTER, NJ |
| RICHARD J RUBINO | Executive Officer | BEDMINSTER, NJ |
| James Mazzo | Director | EVEN YEHUDA, L3 |
| Gerald Cagle | Director | Fort Worth, TX |
| Brian Levy | Executive Officer | Syosset, NY |
| Anand Mehra | Director | Wayne, PA |
| David Gryska | Director | Dallas, TX |
| Richard Rubino | Executive Officer | Boston, MA |
| David Epstein | Director | San Francisco, CA |
| David Epstein | Executive Officer | San Francisco, CA |
| Dennis Henner | Director | Burlingame, CA |
| Geoffrey Duyk | Director | EMERYVILLE, CA |
| VICENTE ANIDO | Director | BEDMINSTER, NJ |
| VICENTE ANIDO | Executive Officer | BEDMINSTER, NJ |
| MURRAY GOLDBERG | Director | BEDMINSTER, NJ |
| CASEY KOPCZYNSKI | Executive Officer | BEDMINSTER, NJ |
| THOMAS MITRO | Executive Officer | BEDMINSTER, NJ |
| DAVID J EPSTEIN | Director | BEDMINSTER, NJ |
| DENNIS J HENNER | Director | BEDMINSTER, NJ |
| THOMAS J VAN HAARLEM | Director | BEDMINSTER, NJ |
| THOMAS J VAN HAARLEM | Executive Officer | BEDMINSTER, NJ |
| DAVID J MACK | Director | BEDMINSTER, NJ |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2014-09-23 | D | $125.0M | $125.0M |
| 2012-12-19 | D | $15.0M | $3.0M |
| 2011-03-01 | D | $41.4M | $41.4M |
| 2010-09-01 | D | $5.3M | $5.3M |